Current views on the clinical relevance of blastocystis spp.

被引:141
作者
Tan K.S.W. [1 ]
Mirza H. [1 ]
Teo J.D.W. [1 ]
Wu B. [1 ]
MacAry P.A. [1 ]
机构
[1] Laboratory of Molecular and Cellular Parasitology, Department of Microbiology, National University of Singapore, Singapore 117597
基金
英国医学研究理事会;
关键词
Blastocystis; Diagnosis; Pathogenesis; Prevalence; Subtypes;
D O I
10.1007/s11908-009-0073-8
中图分类号
学科分类号
摘要
Blastocystis is an enteric protistan parasite of uncertain clinical relevance. Recent studies indicate that the parasite is a species complex and humans are potentially hosts to nine Blastocystis subtypes, most of which are zoonotic. Subtype 3 is the most common in prevalence studies, followed by subtype 1. Laboratory diagnosis is challenging; the currently recommended diagnostic approach is trichrome staining of direct smears coupled with stool culture. Polymerase chain reaction testing from stools or culture is useful for determining Blastocystis subtype information. The controversial pathogenesis of Blastocystis is attributed to subtype variations in virulence; although current studies seem to support this idea, evidence suggests other factors also contribute to the clinical outcome of the infection. Clinical signs and symptoms of blastocystosis include abdominal pain, diarrhea, bloating, and flatulence. Extraintestinal manifestations, predominantly cutaneous, also were reported. In vitro and animal studies shed new light on the pathobiology of Blastocystis. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码:28 / 35
页数:7
相关论文
共 51 条
[1]  
Tan K.S., New insights on classification, identification, and clinical relevance of Blastocystis spp, Clin Microbiol Rev, 21, pp. 639-665, (2008)
[2]  
Stensvold C.R., Lewis H.C., Hammerum A.M., Et al., Blastocystis: Unraveling potential risk factors and clinical significance of a common but neglected parasite, Epidemiol Infect, 137, pp. 1655-1663, (2009)
[3]  
Stensvold C.R., Arendrup M.C., Nielsen H.V., Molbak K., Blastocystis-an enigmatic parasite [in Danish], Ugeskr Laeger, 171, pp. 2388-2390, (2009)
[4]  
Dominguez-Marquez M.V., Guna R., Munoz C., Borras R., High prevalence of subtype 4 among isolates of Blastocystis hominis from symptomatic patients of a health district of Valencia (Spain), Parasitol Res, 105, pp. 949-955, (2009)
[5]  
Eroglu F., Genc A., Elgun G., Koltas I.S., Identification of Blastocystis hominis isolates from asymptomatic and symptomatic patients by PCR, Parasitol Res, 105, pp. 1589-1592, (2009)
[6]  
Stensvold C.R., Suresh G.K., Tan K.S.W., Thompson R.C.A., Traub R.J., Viscogliosi E., Yoshikawa H., Clark C.G., Terminology for Blastocystis subtypes - a consensus, Trends in Parasitology, 23, 3, pp. 93-96, (2007)
[7]  
Hu K.-C., Lin C.-C., Wang T.-E., Liu C.-Y., Chen M.-J., Chang W.-H., Amoebic liver abscess or is it?, Gut, 57, 5, (2008)
[8]  
Patino W.D., Cavuoti D., Banerjee S.K., Et al., Cytologic diagnosis of Blastocystis hominis in peritoneal fluid: A case report, Acta Cytol, 52, pp. 718-720, (2008)
[9]  
Kaya S., Cetin E.S., Aridogan B.C., Et al., Pathogenicity of Blastocystis hominis, a clinical reevaluation, Turkiye Parazitol Derg, 31, pp. 184-187, (2007)
[10]  
Moghaddam D.D., Ghadirian E., Azami M., Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole, Parasitology Research, 96, 4, pp. 273-275, (2005)